Skip to main content
. 2023 Aug 18;15(12):1070–1080. doi: 10.1111/1753-0407.13457

TABLE 1.

BMI and prescriptions used in the samples for lipidomic analysis.

Groups Healthy control (n = 6) Diabetic without cardiovascular diseases DM (n = 6) Diabetic with cardiovascular diseases DM‐CAD (n = 6)
BMI 24.4 ± 1.35 24.1 ± 1.48 25.9 ± 2.03
Oral antidiabetic prescriptions None

Two or three oral anti‐diabetic drugs in combination:

(1) Dapagliflozin, 10 mg qd;

(2) Saxagliptin, 5 mg qd;

(3) Metformin, 500 mg bid;

(4) Glimepirid, 4 mg qd;

(5) Acarbose 50 mg tid;

Two or three oral anti‐diabetic drugs in combination:

(1) Dapagliflozin, 10 mg qd;

(2) Saxagliptin, 5 mg qd;

(3) Metformin, 500 mg bid

(4) Glimepirid, 4 mg qd;

(5) Acarbose 50 mg tid;
Insulin None None None

Abbreviations: BMI, body mass index; DM‐CAD, diabetes patients with cardiovascular disease.